both are WADA-prohibited
In the landmark SELECT trial, semaglutide 2.4 mg demonstrated a 20% relative risk reduction in major adverse cardiovascular events in over 17,000 patients with obesity but without diabetes
The purpose of this article is to provide a comprehensive understanding of how semaglutide might cause skin sensitivity and what you can do about it
10.1111/cns.12788 85 MoranM
[12] Very high cumulative exposure over months may encourage calcium deposition in soft tissues such as the renal parenchyma or coronary arteries, an outcome implicated in observational studies linking supra-physiological 25-hydroxyvitamin D levels with vascular calcification and heightened fracture risk in frail elders
1 Collectively, tumor-intrinsic mechanisms, spanning genetic mutation, epigenetic reprogramming, immune checkpoint activation, and cellular plasticity, converge to create a highly adaptable, treatment-refractory phenotype